Format

Send to

Choose Destination
Gut. 2019 Feb;68(2):374-376. doi: 10.1136/gutjnl-2018-316057. Epub 2018 Feb 22.

Association between proton pump inhibitors use and risk of gastric cancer in patients with GERD.

Peng YC#1,2, Huang LR#3, Lin CL4,5, Hsu WY6, Chang CS1, Yeh HZ1,2, Kao CH7,8,9.

Author information

1
Division of Gastroenterology, Department of Internal Medicine, Taichung Veterans General Hospital, Taichung, Taiwan.
2
National Yang-Ming University, Taipei, Taiwan.
3
Department of Medical Laboratory Science and Biotechnology, Central Taiwan University of Science and Technology, Taichung, Taiwan.
4
Management Office for Health Data, China Medical University Hospital, Taichung, Taiwan.
5
College of Medicine, China Medical University, Taichung, Taiwan.
6
Department of Nursing, Taichung Veterans General Hospital, Taichung, Taiwan.
7
Graduate Institute of Clinical Medicine Science and School of Medicine, College of Medicine, China Medical University, Taichung, Taiwan.
8
Department of Nuclear Medicine and PET Center, China Medical University Hospital, Taichung, Taiwan.
9
Department of Bioinformatics and Medical Engineering, Asia University, Taichung, Taiwan.
#
Contributed equally

KEYWORDS:

Gastric Cancer; Proton Pump Inhibition

PMID:
29472295
DOI:
10.1136/gutjnl-2018-316057
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for HighWire
Loading ...
Support Center